期刊文献+

寻常型银屑病患者外周血血清IL-33、IL-38的表达及意义 被引量:3

Expression of IL-33 and IL-38 in Peripheral Blood of Patients with Psoriasis Vulgaris
下载PDF
导出
摘要 目的通过检测白细胞介素(IL)-33、IL-38在不同病期寻常型银屑病患者外周血血清中的表达,探讨两者在寻常型银屑病发病机制中的作用。方法分别采集寻常型银屑病进行期(22例)、静止期(20例)、退行期(21例)患者及32例健康对照者外周血,采用竞争性免疫抑制酶联免疫吸附测定(ELISA)法检测寻常型银屑病患者不同病期及健康对照组外周血血清IL-33、IL-38表达水平。结果寻常型银屑病进行期血清IL-33[(69.08±11.54)pg/mL]表达水平显著高于静止期[(58.18±16.38)pg/mL]、退行期[(54.65±14.81)pg/mL]、健康对照组[(60.85±14.11)pg/mL],差异有统计学意义(均P<0.05);静止期、退行期、与健康对照组组间比较,差异无统计学意义(P>0.05)。寻常型银屑病患者进行期、静止期、退行期IL-38[(40.70±9.17)pg/mL,(84.54±17.59)pg/mL,(78.88±14.32)pg/mL]水平与健康对照组[(139.81±23.35)pg/mL]相比,差异有统计学意义(均P<0.05);静止期、退行期血清IL-38水平显著高于进行期,差异有统计学意义(均P<0.05)。静止期血清IL-38表达水平高于退行期,差异无统计学意义(P>0.05)。结论 IL-33、IL-38可能参与寻常型银屑病的发病。 Objective In order to detect the expression of IL-33 and IL-38 in peripheral blood of patients with psoriasis vulgaris. Methods Serum concentrations of IL-33 and IL-38 were measured by competitive enzyme linked immunosorbent assay(ELISA) in 63 cases of PV patients, including 22 cases in progressive, 20 cases in stationary, and 21 cases in regressive stage, as well as 32 healthy volunteers. Results The expression of serum IL-33 were significantly higher in progressive(69.08±11.54 pg/mL) of PV than in static [(58.18±16.38) pg/mL], paracmasis [(54.65±14.81) pg/mL] and healthy control[(60.85±14.11) pg/mL, all P0.05). There were no significant difference between the group in static, paracmasis of PV and healthy control(P0.05). The levels of serum IL-38 were significant higher in progressive [(40.70 ±9.17) pg/mL], static[(84.54±17.59) pg/mL] and paracmasis[(78.88±14.32) pg/mL] of PV than in healthy controls [(139.81±23.35) pg/mL, all P0.05]. The level of IL-38 was increased significantly in static and paracmasis compared to progressive of PV(all P0.05).The expression of IL-38 in static were higher than that in paracmasis, but there was no significant difference(P0.05).Conclusion IL-33 and IL-38 may be involved in the pathogenesis of psoriasis vulgaris.
作者 宋延枫 王秀敏 廉信 宋琼 Song Yanfeng;Wang Xiumin;Lian Xin;Song Qiong(Huantai People's Hospital in Shandong Province,Huantai 256400,China;Affiliated Hospital of Binzhou MedicalUniversity in Shandong Province,Binzhou 256603,China)
出处 《中国中西医结合皮肤性病学杂志》 CAS 2018年第3期215-217,共3页 Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine
关键词 寻常型银屑病 白细胞介素33 白细胞介素38 Psoriasis vulgaris Interleukin-33 Interleukin-38
  • 相关文献

参考文献1

二级参考文献25

  • 1张临友,修殿辉,杨宝峰.Toll样受体与免疫排斥[J].国际免疫学杂志,2006,29(4):209-213. 被引量:2
  • 2Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood, 2011, 117 (14) : 3720-3732.
  • 3Dinarello CA. hnmunological and inflammatory functions of the interleukin-I family. Annu Rev Immunol, 2009, 27: 519-550.
  • 4Dinarello C, Arend W, Sims J, et al. IL-1 family nomenclature. Nat Immunol, 2010, 11(11): 973.
  • 5Lin H, Ho AS, Haley-Vicente D, et al. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol Chem, 2001, 276(23): 20597-20602.
  • 6van Asseldonk E J, Stienstra R, Koenen TB, et al. The effect of the interleukin-1 cytokine family members IL-1 F6 and IL-1 F8 on adipocyte differentiation. Obesity ( Silver Spring ) , 2010, 18 ( 11 ) : 2234-2236.
  • 7van de Veerdonk FL, Stoeckman AK, Wu G, et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci U S A, 2012, 109(8) : 3001-3005.
  • 8Stenerson M, Dufendach K, Aksentijevich I, et al. The first reported case of compound heterozygous ILIRN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis Rheum, 2011,63( 12): 4018-4022.
  • 9Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin-1 -receptor antagonist. N Engl J Med, 2009, 360(23) : 2426-2437.
  • 10Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med, 2011, 365(7) : 620-628.

共引文献3

同被引文献27

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部